Experienced in Eosinophilic Cystitis

Dr. Alan W. Skolnick

Urology
915 Gessner Rd, Suite 720, 
Houston, TX 
Experienced in Eosinophilic Cystitis
915 Gessner Rd, Suite 720, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Alan Skolnick is an Urologist in Houston, Texas. Dr. Skolnick is rated as an Experienced provider by MediFind in the treatment of Eosinophilic Cystitis. His top areas of expertise are Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Enlarged Prostate (BPH), and Acute Cystitis.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Urology
Licenses
Urology in TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

915 Gessner Rd, Suite 720, Houston, TX 77024

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 2 Randomized, Double-blind, Placebo-controlled Trial and Open Label Extension to Evaluate the Safety and Efficacy of Deupirfenidone (LYT-100) in Post-acute COVID-19 Respiratory Disease
A Phase 2 Randomized, Double-blind, Placebo-controlled Trial and Open Label Extension to Evaluate the Safety and Efficacy of Deupirfenidone (LYT-100) in Post-acute COVID-19 Respiratory Disease
Enrollment Status: Terminated
Publish Date: February 14, 2024
Intervention Type: Drug, Other
Study Drug: Deupirfenidone
Study Phase: Phase 2
A Randomized Double-Blind, Sponsor-Open, Double-Dummy, Proof of Concept Phase 2 Study to Evaluate the Efficacy and Safety of TAK-951 Versus Ondansetron in the Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Subjects
A Randomized Double-Blind, Sponsor-Open, Double-Dummy, Proof of Concept Phase 2 Study to Evaluate the Efficacy and Safety of TAK-951 Versus Ondansetron in the Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Subjects
Enrollment Status: Completed
Publish Date: April 21, 2023
Intervention Type: Drug
Study Phase: Phase 2
Phase 3, Randomized, Placebo-Controlled, Efficacy and Safety Study of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS).
Phase 3, Randomized, Placebo-Controlled, Efficacy and Safety Study of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS).
Enrollment Status: Completed
Publish Date: April 18, 2023
Intervention Type: Drug
Study Drug: VERU-111
Study Phase: Phase 3
A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With Standard of Care Versus Standard of Care in Subjects Hospitalized With COVID-19
A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With Standard of Care Versus Standard of Care in Subjects Hospitalized With COVID-19
Enrollment Status: Completed
Publish Date: January 18, 2023
Intervention Type: Drug, Other
Study Drug: Abivertinib
Study Phase: Phase 2
View 3 Less Clinical Trials

3 Total Publications

Evaluation of the potential of Rejuveinix plus dexamethasone against sepsis.
Evaluation of the potential of Rejuveinix plus dexamethasone against sepsis.
Journal: Future microbiology
Published: September 02, 2022
Similar Doctors
Advanced in Eosinophilic Cystitis
Dr. Christina K. Pramudji
Urology
Advanced in Eosinophilic Cystitis
Dr. Christina K. Pramudji
Urology

Houston Female Urology PA

18300 Katy Fwy, Suite 565, 
Houston, TX 
 (1.7 miles away)
281-717-4003
Languages Spoken:
English
See accepted insurances

Christina Pramudji is an Urologist in Houston, Texas. Dr. Pramudji is rated as a Distinguished provider by MediFind in the treatment of Eosinophilic Cystitis. Her top areas of expertise are Urinary Incontinence, Stress Urinary Incontinence, Urinary Tract Infection in Children, and Urinary Tract Infection (UTI).

Advanced in Eosinophilic Cystitis
Dr. Samir P. Shirodkar
Urology
Advanced in Eosinophilic Cystitis
Dr. Samir P. Shirodkar
Urology

Spring Creek Urology Specialists LLC

9305 Pinecroft Dr, Suite 304, 
The Woodlands, TX 
 (27.7 miles away)
936-441-1005
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Samir Shirodkar is an Urologist in The Woodlands, Texas. Dr. Shirodkar is rated as a Distinguished provider by MediFind in the treatment of Eosinophilic Cystitis. His top areas of expertise are Renal Cell Carcinoma (RCC), Urinary Tract Infection in Children, Eunuchoidism Familial Hypogonadotropic, Nephrectomy, and Ureteroscopy. Dr. Shirodkar is currently accepting new patients.

Experienced in Eosinophilic Cystitis
Dr. Ned B. Stein
Urology
Experienced in Eosinophilic Cystitis
Dr. Ned B. Stein
Urology

Ned B Stein, Md, PA

7777 Southwest Fwy, Suite 514, 
Houston, TX 
 (6.1 miles away)
713-776-8888
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Ned Stein is an Urologist in Houston, Texas. Dr. Stein is rated as an Advanced provider by MediFind in the treatment of Eosinophilic Cystitis. His top areas of expertise are Enlarged Prostate (BPH), Prostate Cancer, Familial Prostate Cancer, Eunuchoidism Familial Hypogonadotropic, and Prostatectomy. Dr. Stein is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Skolnick's expertise for a condition
ConditionClose
        View All 17 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile